Latest article
Novo Nordisk to launch GLP-1 injectible diabetes drug in pill type by February
Novo Nordisk, headquartered in Denmark and a leader in the diabetes market, plans to launch this oral GLP-1 drug in India by February 2022....
Sort 2 diabetes can enhance threat of Parkinson’s illness
Research from Queen Mary University in London found compelling evidence that type...